KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $81.9 billion.

  • Amgen's Total Liabilities fell 469.28% to $81.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $81.9 billion, marking a year-over-year decrease of 469.28%. This contributed to the annual value of $81.9 billion for FY2025, which is 469.28% down from last year.
  • Per Amgen's latest filing, its Total Liabilities stood at $81.9 billion for Q4 2025, which was down 469.28% from $80.5 billion recorded in Q3 2025.
  • In the past 5 years, Amgen's Total Liabilities ranged from a high of $90.9 billion in Q4 2023 and a low of $51.5 billion during Q2 2021
  • For the 5-year period, Amgen's Total Liabilities averaged around $73.1 billion, with its median value being $81.2 billion (2025).
  • Its Total Liabilities has fluctuated over the past 5 years, first surged by 4793.69% in 2023, then tumbled by 545.52% in 2024.
  • Over the past 5 years, Amgen's Total Liabilities (Quarter) stood at $54.5 billion in 2021, then rose by 12.84% to $61.5 billion in 2022, then surged by 47.94% to $90.9 billion in 2023, then decreased by 5.46% to $86.0 billion in 2024, then fell by 4.69% to $81.9 billion in 2025.
  • Its last three reported values are $81.9 billion in Q4 2025, $80.5 billion for Q3 2025, and $80.5 billion during Q2 2025.